急性片頭痛治療の世界市場 2020年

• 英文タイトル：Global Acute Migraine Treatments Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：GIR201113481 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール • 産業分類：医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本書では、急性片頭痛治療の世界市場を調査対象にし、急性片頭痛治療の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（薬、パッチ、その他）、用途別分析（病院薬局、ドラッグストア、小売薬局、オンライン薬局）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Amgen、Abbott、Eli Lily、Pfizer、Allergan、Novartis、Teva Pharmaceutical、AstraZeneca ・企業別売上、市場シェア ・急性片頭痛治療の地域別市場分析 ・急性片頭痛治療の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・急性片頭痛治療のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・急性片頭痛治療のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・急性片頭痛治療の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・急性片頭痛治療の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・急性片頭痛治療の種類別市場規模2015-2020：薬、パッチ、その他 ・急性片頭痛治療の用途別市場規模2015-2020：病院薬局、ドラッグストア、小売薬局、オンライン薬局 ・急性片頭痛治療の世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論

Market Overview
The global Acute Migraine Treatments market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Acute Migraine Treatments market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Acute Migraine Treatments market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Acute Migraine Treatments market has been segmented into:
Drugs
Patches
Others

By Application, Acute Migraine Treatments has been segmented into:
Hospital Pharmacies
Drug Stores
Retail Pharmacies
Online Pharmacies

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Acute Migraine Treatments market presented in the report. This section sheds light on the sales growth of different regional and country-level Acute Migraine Treatments markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Acute Migraine Treatments market.

The report offers in-depth assessment of the growth and other aspects of the Acute Migraine Treatments market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Acute Migraine Treatments Market Share Analysis
Acute Migraine Treatments competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Acute Migraine Treatments sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Acute Migraine Treatments sales, revenue and market share for each player covered in this report.

The major players covered in Acute Migraine Treatments are:
Amgen
Abbott
Eli Lily
Pfizer
Allergan
Novartis
Teva Pharmaceutical
AstraZeneca

レポート目次

---

1 Acute Migraine Treatments Market Overview
1.1 Product Overview and Scope of Acute Migraine Treatments
1.2 Classification of Acute Migraine Treatments by Type
1.2.1 Global Acute Migraine Treatments Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Acute Migraine Treatments Revenue Market Share by Type in 2019
1.2.3 Drugs
1.2.4 Patches
1.2.5 Others
1.3 Global Acute Migraine Treatments Market by Application
1.3.1 Overview: Global Acute Migraine Treatments Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital Pharmacies
1.3.3 Drug Stores
1.3.4 Retail Pharmacies
1.3.5 Online Pharmacies
1.4 Global Acute Migraine Treatments Market by Regions
1.4.1 Global Acute Migraine Treatments Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Acute Migraine Treatments (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Acute Migraine Treatments Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Acute Migraine Treatments Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Acute Migraine Treatments Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Acute Migraine Treatments Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Acute Migraine Treatments Status and Prospect (2015-2025)
2 Company Profiles
2.1 Amgen
2.1.1 Amgen Details
2.1.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Amgen SWOT Analysis
2.1.4 Amgen Product and Services
2.1.5 Amgen Acute Migraine Treatments Revenue, Gross Margin and Market Share (2018-2019)
2.2 Abbott
2.2.1 Abbott Details
2.2.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Abbott SWOT Analysis
2.2.4 Abbott Product and Services
2.2.5 Abbott Acute Migraine Treatments Revenue, Gross Margin and Market Share (2018-2019)
2.3 Eli Lily
2.3.1 Eli Lily Details
2.3.2 Eli Lily Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Eli Lily SWOT Analysis
2.3.4 Eli Lily Product and Services
2.3.5 Eli Lily Acute Migraine Treatments Revenue, Gross Margin and Market Share (2018-2019)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Pfizer SWOT Analysis
2.4.4 Pfizer Product and Services
2.4.5 Pfizer Acute Migraine Treatments Revenue, Gross Margin and Market Share (2018-2019)
2.5 Allergan
2.5.1 Allergan Details
2.5.2 Allergan Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Allergan SWOT Analysis
2.5.4 Allergan Product and Services
2.5.5 Allergan Acute Migraine Treatments Revenue, Gross Margin and Market Share (2018-2019)
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Novartis SWOT Analysis
2.6.4 Novartis Product and Services
2.6.5 Novartis Acute Migraine Treatments Revenue, Gross Margin and Market Share (2018-2019)
2.7 Teva Pharmaceutical
2.7.1 Teva Pharmaceutical Details
2.7.2 Teva Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Teva Pharmaceutical SWOT Analysis
2.7.4 Teva Pharmaceutical Product and Services
2.7.5 Teva Pharmaceutical Acute Migraine Treatments Revenue, Gross Margin and Market Share (2018-2019)
2.8 AstraZeneca
2.8.1 AstraZeneca Details
2.8.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 AstraZeneca SWOT Analysis
2.8.4 AstraZeneca Product and Services
2.8.5 AstraZeneca Acute Migraine Treatments Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Acute Migraine Treatments Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Acute Migraine Treatments Players Market Share
3.2.2 Top 10 Acute Migraine Treatments Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Acute Migraine Treatments Revenue and Market Share by Regions
4.2 North America Acute Migraine Treatments Revenue and Growth Rate (2015-2020)
4.3 Europe Acute Migraine Treatments Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Acute Migraine Treatments Revenue and Growth Rate (2015-2020)
4.5 South America Acute Migraine Treatments Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Acute Migraine Treatments Revenue and Growth Rate (2015-2020)
5 North America Acute Migraine Treatments Revenue by Countries
5.1 North America Acute Migraine Treatments Revenue by Countries (2015-2020)
5.2 USA Acute Migraine Treatments Revenue and Growth Rate (2015-2020)
5.3 Canada Acute Migraine Treatments Revenue and Growth Rate (2015-2020)
5.4 Mexico Acute Migraine Treatments Revenue and Growth Rate (2015-2020)
6 Europe Acute Migraine Treatments Revenue by Countries
6.1 Europe Acute Migraine Treatments Revenue by Countries (2015-2020)
6.2 Germany Acute Migraine Treatments Revenue and Growth Rate (2015-2020)
6.3 UK Acute Migraine Treatments Revenue and Growth Rate (2015-2020)
6.4 France Acute Migraine Treatments Revenue and Growth Rate (2015-2020)
6.5 Russia Acute Migraine Treatments Revenue and Growth Rate (2015-2020)
6.6 Italy Acute Migraine Treatments Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Acute Migraine Treatments Revenue by Countries
7.1 Asia-Pacific Acute Migraine Treatments Revenue by Countries (2015-2020)
7.2 China Acute Migraine Treatments Revenue and Growth Rate (2015-2020)
7.3 Japan Acute Migraine Treatments Revenue and Growth Rate (2015-2020)
7.4 Korea Acute Migraine Treatments Revenue and Growth Rate (2015-2020)
7.5 India Acute Migraine Treatments Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Acute Migraine Treatments Revenue and Growth Rate (2015-2020)
8 South America Acute Migraine Treatments Revenue by Countries
8.1 South America Acute Migraine Treatments Revenue by Countries (2015-2020)
8.2 Brazil Acute Migraine Treatments Revenue and Growth Rate (2015-2020)
8.3 Argentina Acute Migraine Treatments Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Acute Migraine Treatments by Countries
9.1 Middle East & Africa Acute Migraine Treatments Revenue by Countries (2015-2020)
9.2 Saudi Arabia Acute Migraine Treatments Revenue and Growth Rate (2015-2020)
9.3 UAE Acute Migraine Treatments Revenue and Growth Rate (2015-2020)
9.4 Egypt Acute Migraine Treatments Revenue and Growth Rate (2015-2020)
9.5 South Africa Acute Migraine Treatments Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Acute Migraine Treatments Revenue and Market Share by Type (2015-2020)
10.2 Global Acute Migraine Treatments Market Forecast by Type (2019-2024)
10.3 Drugs Revenue Growth Rate (2015-2025)
10.4 Patches Revenue Growth Rate (2015-2025)
10.5 Others Revenue Growth Rate (2015-2025)
11 Global Acute Migraine Treatments Market Segment by Application
11.1 Global Acute Migraine Treatments Revenue Market Share by Application (2015-2020)
11.2 Acute Migraine Treatments Market Forecast by Application (2019-2024)
11.3 Hospital Pharmacies Revenue Growth (2015-2020)
11.4 Drug Stores Revenue Growth (2015-2020)
11.5 Retail Pharmacies Revenue Growth (2015-2020)
11.6 Online Pharmacies Revenue Growth (2015-2020)
12 Global Acute Migraine Treatments Market Size Forecast (2021-2025)
12.1 Global Acute Migraine Treatments Market Size Forecast (2021-2025)
12.2 Global Acute Migraine Treatments Market Forecast by Regions (2021-2025)
12.3 North America Acute Migraine Treatments Revenue Market Forecast (2021-2025)
12.4 Europe Acute Migraine Treatments Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Acute Migraine Treatments Revenue Market Forecast (2021-2025)
12.6 South America Acute Migraine Treatments Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Acute Migraine Treatments Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables
Table 1. Global Acute Migraine Treatments Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Acute Migraine Treatments by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Acute Migraine Treatments Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Acute Migraine Treatments Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Amgen Corporate Information, Location and Competitors
Table 6. Amgen Acute Migraine Treatments Major Business
Table 7. Amgen Acute Migraine Treatments Total Revenue (USD Million) (2017-2018)
Table 8. Amgen SWOT Analysis
Table 9. Amgen Acute Migraine Treatments Product and Solutions
Table 10. Amgen Acute Migraine Treatments Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Abbott Corporate Information, Location and Competitors
Table 12. Abbott Acute Migraine Treatments Major Business
Table 13. Abbott Acute Migraine Treatments Total Revenue (USD Million) (2018-2019)
Table 14. Abbott SWOT Analysis
Table 15. Abbott Acute Migraine Treatments Product and Solutions
Table 16. Abbott Acute Migraine Treatments Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Eli Lily Corporate Information, Location and Competitors
Table 18. Eli Lily Acute Migraine Treatments Major Business
Table 19. Eli Lily Acute Migraine Treatments Total Revenue (USD Million) (2017-2018)
Table 20. Eli Lily SWOT Analysis
Table 21. Eli Lily Acute Migraine Treatments Product and Solutions
Table 22. Eli Lily Acute Migraine Treatments Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Pfizer Corporate Information, Location and Competitors
Table 24. Pfizer Acute Migraine Treatments Major Business
Table 25. Pfizer Acute Migraine Treatments Total Revenue (USD Million) (2017-2018)
Table 26. Pfizer SWOT Analysis
Table 27. Pfizer Acute Migraine Treatments Product and Solutions
Table 28. Pfizer Acute Migraine Treatments Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Allergan Corporate Information, Location and Competitors
Table 30. Allergan Acute Migraine Treatments Major Business
Table 31. Allergan Acute Migraine Treatments Total Revenue (USD Million) (2017-2018)
Table 32. Allergan SWOT Analysis
Table 33. Allergan Acute Migraine Treatments Product and Solutions
Table 34. Allergan Acute Migraine Treatments Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Novartis Corporate Information, Location and Competitors
Table 36. Novartis Acute Migraine Treatments Major Business
Table 37. Novartis Acute Migraine Treatments Total Revenue (USD Million) (2017-2018)
Table 38. Novartis SWOT Analysis
Table 39. Novartis Acute Migraine Treatments Product and Solutions
Table 40. Novartis Acute Migraine Treatments Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Teva Pharmaceutical Corporate Information, Location and Competitors
Table 42. Teva Pharmaceutical Acute Migraine Treatments Major Business
Table 43. Teva Pharmaceutical Acute Migraine Treatments Total Revenue (USD Million) (2017-2018)
Table 44. Teva Pharmaceutical SWOT Analysis
Table 45. Teva Pharmaceutical Acute Migraine Treatments Product and Solutions
Table 46. Teva Pharmaceutical Acute Migraine Treatments Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. AstraZeneca Corporate Information, Location and Competitors
Table 48. AstraZeneca Acute Migraine Treatments Major Business
Table 49. AstraZeneca Acute Migraine Treatments Total Revenue (USD Million) (2017-2018)
Table 50. AstraZeneca SWOT Analysis
Table 51. AstraZeneca Acute Migraine Treatments Product and Solutions
Table 52. AstraZeneca Acute Migraine Treatments Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Global Acute Migraine Treatments Revenue (Million USD) by Players (2015-2020)
Table 54. Global Acute Migraine Treatments Revenue Share by Players (2015-2020)
Table 55. Global Acute Migraine Treatments Revenue (Million USD) by Regions (2015-2020)
Table 56. Global Acute Migraine Treatments Revenue Market Share by Regions (2015-2020)
Table 57. North America Acute Migraine Treatments Revenue by Countries (2015-2020)
Table 58. North America Acute Migraine Treatments Revenue Market Share by Countries (2015-2020)
Table 59. Europe Acute Migraine Treatments Revenue (Million USD) by Countries (2015-2020)
Table 60. Asia-Pacific Acute Migraine Treatments Revenue (Million USD) by Countries (2015-2020)
Table 61. South America Acute Migraine Treatments Revenue by Countries (2015-2020)
Table 62. South America Acute Migraine Treatments Revenue Market Share by Countries (2015-2020)
Table 63. Middle East and Africa Acute Migraine Treatments Revenue (Million USD) by Countries (2015-2020)
Table 64. Middle East and Africa Acute Migraine Treatments Revenue Market Share by Countries (2015-2020)
Table 65. Global Acute Migraine Treatments Revenue (Million USD) by Type (2015-2020)
Table 66. Global Acute Migraine Treatments Revenue Share by Type (2015-2020)
Table 67. Global Acute Migraine Treatments Revenue Forecast by Type (2021-2025)
Table 68. Global Acute Migraine Treatments Revenue by Application (2015-2020)
Table 69. Global Acute Migraine Treatments Revenue Share by Application (2015-2020)
Table 70. Global Acute Migraine Treatments Revenue Forecast by Application (2021-2025)
Table 71. Global Acute Migraine Treatments Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Acute Migraine Treatments Picture
Figure 2. Global Acute Migraine Treatments Revenue Market Share by Type in 2019
Figure 3. Drugs Picture
Figure 4. Patches Picture
Figure 5. Others Picture
Figure 6. Acute Migraine Treatments Revenue Market Share by Application in 2019
Figure 7. Hospital Pharmacies Picture
Figure 8. Drug Stores Picture
Figure 9. Retail Pharmacies Picture
Figure 10. Online Pharmacies Picture
Figure 11. Global Acute Migraine Treatments Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Acute Migraine Treatments Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Acute Migraine Treatments Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Acute Migraine Treatments Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Acute Migraine Treatments Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Acute Migraine Treatments Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Acute Migraine Treatments Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Acute Migraine Treatments Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Acute Migraine Treatments Revenue Market Share in 2019
Figure 20. Global Top 10 Players Acute Migraine Treatments Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Acute Migraine Treatments Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Acute Migraine Treatments Revenue Market Share by Regions (2015-2020)
Figure 24. Global Acute Migraine Treatments Revenue Market Share by Regions in 2018
Figure 25. North America Acute Migraine Treatments Revenue and Growth Rate (2015-2020)
Figure 26. Europe Acute Migraine Treatments Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Acute Migraine Treatments Revenue and Growth Rate (2015-2020)
Figure 28. South America Acute Migraine Treatments Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Acute Migraine Treatments Revenue and Growth Rate (2015-2020)
Figure 30. North America Acute Migraine Treatments Revenue Market Share by Countries (2015-2020)
Figure 31. North America Acute Migraine Treatments Revenue Market Share by Countries in 2019
Figure 32. USA Acute Migraine Treatments Revenue and Growth Rate (2015-2020)
Figure 33. Canada Acute Migraine Treatments Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Acute Migraine Treatments Revenue and Growth Rate (2015-2020)
Figure 35. Europe Acute Migraine Treatments Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Acute Migraine Treatments Revenue Market Share by Countries in 2019
Figure 37. Germany Acute Migraine Treatments Revenue and Growth Rate (2015-2020)
Figure 38. UK Acute Migraine Treatments Revenue and Growth Rate (2015-2020)
Figure 39. France Acute Migraine Treatments Revenue and Growth Rate (2015-2020)
Figure 40. Russia Acute Migraine Treatments Revenue and Growth Rate (2015-2020)
Figure 41. Italy Acute Migraine Treatments Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Acute Migraine Treatments Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Acute Migraine Treatments Revenue Market Share by Countries in 2019
Figure 44. China Acute Migraine Treatments Revenue and Growth Rate (2015-2020)
Figure 45. Japan Acute Migraine Treatments Revenue and Growth Rate (2015-2020)
Figure 46. Korea Acute Migraine Treatments Revenue and Growth Rate (2015-2020)
Figure 47. India Acute Migraine Treatments Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Acute Migraine Treatments Revenue and Growth Rate (2015-2020)
Figure 49. South America Acute Migraine Treatments Revenue Market Share by Countries (2015-2020)
Figure 50. South America Acute Migraine Treatments Revenue Market Share by Countries in 2019
Figure 51. Brazil Acute Migraine Treatments Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Acute Migraine Treatments Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Acute Migraine Treatments Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Acute Migraine Treatments Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Acute Migraine Treatments Revenue and Growth Rate (2015-2020)
Figure 56. UAE Acute Migraine Treatments Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Acute Migraine Treatments Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Acute Migraine Treatments Revenue and Growth Rate (2015-2020)
Figure 59. Global Acute Migraine Treatments Revenue Share by Type (2015-2020)
Figure 60. Global Acute Migraine Treatments Revenue Share by Type in 2019
Figure 61. Global Acute Migraine Treatments Market Share Forecast by Type (2021-2025)
Figure 62. Global Drugs Revenue Growth Rate (2015-2020)
Figure 63. Global Patches Revenue Growth Rate (2015-2020)
Figure 64. Global Others Revenue Growth Rate (2015-2020)
Figure 65. Global Acute Migraine Treatments Revenue Share by Application (2015-2020)
Figure 66. Global Acute Migraine Treatments Revenue Share by Application in 2019
Figure 67. Global Acute Migraine Treatments Market Share Forecast by Application (2021-2025)
Figure 68. Global Hospital Pharmacies Revenue Growth Rate (2015-2020)
Figure 69. Global Drug Stores Revenue Growth Rate (2015-2020)
Figure 70. Global Retail Pharmacies Revenue Growth Rate (2015-2020)
Figure 71. Global Online Pharmacies Revenue Growth Rate (2015-2020)
Figure 72. Global Acute Migraine Treatments Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Acute Migraine Treatments Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Acute Migraine Treatments Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Acute Migraine Treatments Revenue Market Forecast (2021-2025)
Figure 76. Europe Acute Migraine Treatments Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Acute Migraine Treatments Revenue Market Forecast (2021-2025)
Figure 78. South America Acute Migraine Treatments Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Acute Migraine Treatments Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel

---